These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 14234055)

  • 21. The value of immunohistochemical expression of BAX in formulating a prognosis for canine cutaneous mast cell tumours.
    Strefezzi Rde F; Kleeb SR; Xavier JG; Fukumasu H; Catão-Dias JL
    J Comp Pathol; 2012 May; 146(4):314-9. PubMed ID: 21899858
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cytologic comparison of the percentage of mast cells in lymph node aspirate samples from clinically normal dogs versus dogs with allergic dermatologic disease and dogs with cutaneous mast cell tumors.
    Mutz ML; Boudreaux BB; Royal A; Merchant S; Pucheu-Haston C; Griffith EH; Gieger TL
    J Am Vet Med Assoc; 2017 Aug; 251(4):421-428. PubMed ID: 28763275
    [TBL] [Abstract][Full Text] [Related]  

  • 23. VEGF expression in dog mastocytoma.
    Mederle O; Mederle N; Bocan EV; Ceauşu R; Raica M
    Rev Med Chir Soc Med Nat Iasi; 2010; 114(1):185-8. PubMed ID: 20509299
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HISTAMINE CONTENT OF TRANSPLANTABLE MASTOCYTOMA.
    GROF P; KELENYI G
    Acta Med Acad Sci Hung; 1963; 19():331-43. PubMed ID: 14106838
    [No Abstract]   [Full Text] [Related]  

  • 25. CANINE PERIANAL GLAND TUMORS.
    NIELSEN SW; ATTOSMIS J
    J Am Vet Med Assoc; 1964 Jan; 144():127-35. PubMed ID: 14118013
    [No Abstract]   [Full Text] [Related]  

  • 26. Canine cutaneous mast cell tumors: A combined clinical and pathologic approach to diagnosis, prognosis, and treatment selection.
    Sledge DG; Webster J; Kiupel M
    Vet J; 2016 Sep; 215():43-54. PubMed ID: 27372911
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The prognostic significance of microscopic lymph node metastasis of Patnaik grade I and II/Kiupel low-grade MCTs has not been demonstrated.
    Schulman FY
    Vet Comp Oncol; 2019 Jun; 17(2):208. PubMed ID: 30912263
    [No Abstract]   [Full Text] [Related]  

  • 28. Canine mastocytoma: report of 8 cases diagnosed by fine needle cytology and clinicopathologic correlations.
    Fulciniti F; Di Mattia D; Curcio MP; Bove P; Rota AM; Botti G
    Acta Cytol; 2007; 51(4):616-20. PubMed ID: 17718137
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Quantitative analysis in canine cutaneous mast cell tumors.
    Simeonov R; Simeonova G
    Anal Quant Cytol Histol; 2010 Jun; 32(3):178-81. PubMed ID: 20701073
    [No Abstract]   [Full Text] [Related]  

  • 30. Assessment of Canine Mast Cell Tumor Mortality Risk Based on Clinical, Histologic, Immunohistochemical, and Molecular Features.
    Horta RS; Lavalle GE; Monteiro LN; Souza MCC; Cassali GD; Araújo RB
    Vet Pathol; 2018 Mar; 55(2):212-223. PubMed ID: 29338615
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Letter to the Editor re Hergt et al "Use of a 2-tier histologic grading system for canine cutaneous mast cell tumors on cytology specimens".
    Camus M; Priest H; Koehler J; Driskell E; Ilha M; Rakich P; Krimer P
    Vet Clin Pathol; 2016 Dec; 45(4):531. PubMed ID: 27716984
    [No Abstract]   [Full Text] [Related]  

  • 32. Equine cutaneous mastocytoma: morphology, biological behaviour and evolution of the lesion.
    McEntee MF
    J Comp Pathol; 1991 Feb; 104(2):171-8. PubMed ID: 1865026
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of a modified proportional margins approach for surgical resection of mast cell tumors in dogs: 40 cases (2008-2012).
    Pratschke KM; Atherton MJ; Sillito JA; Lamm CG
    J Am Vet Med Assoc; 2013 Nov; 243(10):1436-41. PubMed ID: 24171373
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bovine mastocytoma-a case report.
    GROTH AH; BAILEY WS; WALKER DF
    J Am Vet Med Assoc; 1960 Aug; 137():241-4. PubMed ID: 13829731
    [No Abstract]   [Full Text] [Related]  

  • 35. [Cutaneous mastocytoma in dogs].
    Nevole M; Halouzka R; Cerný L
    Vet Med (Praha); 1972 Jan; 17(1):33-8. PubMed ID: 4623804
    [No Abstract]   [Full Text] [Related]  

  • 36. [On the pathophysiology of endocrine-active pheochromocytoma, carcinoid and mastocytoma].
    FRANZEN F
    Dtsch Arch Klin Med; 1962; 207():571-84. PubMed ID: 13894728
    [No Abstract]   [Full Text] [Related]  

  • 37. Use of an axial pattern skin flap based on the cranial cutaneous branch of the saphenous artery in the dog.
    Collins JE; Degner DA; Bhandal J
    Vet Comp Orthop Traumatol; 2011; 24(4):307-10. PubMed ID: 21451885
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cutaneous mast cell tumour within a lipoma in a boxer.
    Jakab C; Szász AM; Kulka J; Schaff Z; Rusvai M; Németh T; Gálfi P
    Acta Vet Hung; 2009 Jun; 57(2):263-74. PubMed ID: 19584039
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Surgically planned versus histologically measured lateral tumor margins for resection of cutaneous and subcutaneous mast cell tumors in dogs: 46 cases (2010-2013).
    Risselada M; Mathews KG; Griffith E
    J Am Vet Med Assoc; 2015 Jul; 247(2):184-9. PubMed ID: 26133218
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vinblastine and prednisolone as adjunctive therapy for canine cutaneous mast cell tumors.
    Davies DR; Wyatt KM; Jardine JE; Robertson ID; Irwin PJ
    J Am Anim Hosp Assoc; 2004; 40(2):124-30. PubMed ID: 15007048
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.